enoximone sulfoxide

Known as: 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylsulfinyl)benzoyl)-, (2S-(1(R*(R*)),2R*))- 
 

Topic mentions per year

Topic mentions per year

1987-1994
01219871994

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Enoximone is an imidazole derivative which proved to be a selective inhibitor of the isoenzymes III/IV of the cAMP-specific… (More)
Is this relevant?
1991
1991
Twenty-one patients with heart failure (New York Heart Association [NYHA] class II to IV) received a 24-hour infusion of… (More)
Is this relevant?
1991
1991
Enoximone is a phosphodiesterase inhibitor, which has been studied extensively for use in the management of patients with… (More)
Is this relevant?
Review
1991
Review
1991
Enoximone belongs to the imidazole class of compounds, that possess positive inotropic and vasodilatory activities. These… (More)
Is this relevant?
1990
1990
Cardiac and peripheral vascular effects of enoximone were investigated in a placebo-controlled, crossover, double-blind trial in… (More)
Is this relevant?
1990
1990
The calcium channel blocker nifedipine and the new phosphodiesterase (PDE) inhibitor enoximone are used in the treatment of… (More)
Is this relevant?
1988
1988
Experimental factors and determinants of the protein binding of enoximone (a new cardiotonic agent) were investigated in human… (More)
Is this relevant?
1987
1987
The pharmacokinetics of enoximone and its sulfoxide metabolite were determined following administration of a single oral dose of… (More)
Is this relevant?